Full metadata record
DC FieldValueLanguage
dc.creatorLLufriu, S. (Sara)-
dc.creatorSepulveda, M. (María)-
dc.creatorBlanco, Y. (Yolanda)-
dc.creatorMarin, P. (Pedro)-
dc.creatorMoreno, B. (Beatriz)-
dc.creatorBerenguer, J. (Joan)-
dc.creatorGabilondo, I. (Íñigo)-
dc.creatorMartinez-Heras, E. (Eloy)-
dc.creatorSola-Valls, N. (Nuria)-
dc.creatorArnaiz, J.A. (Joan Albert)-
dc.creatorAndreu, E.J. (Enrique José)-
dc.creatorFernandez, B. (Begoña)-
dc.creatorBullich, S. (Santi)-
dc.creatorSanchez-Dalmau, B. (Bernardo)-
dc.creatorGraus, F. (Francesc)-
dc.creatorVilloslada, P. (Pablo)-
dc.creatorSaiz, A. (Albert)-
dc.date.accessioned2015-05-07T10:26:44Z-
dc.date.available2015-05-07T10:26:44Z-
dc.date.issued2014-
dc.identifier.citationLlufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, et al. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One. 2014 Dec 1;9(12):e113936.es_ES
dc.identifier.issn1932-6203-
dc.identifier.urihttps://hdl.handle.net/10171/38250-
dc.description.abstractBone-marrow-MSCs are safe and may reduce inflammatory MRI parameters supporting their immunomodulatory properties. ClinicalTrials.gov NCT01228266.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectInflamatory MRIes_ES
dc.subjectMesenchymal stem cellses_ES
dc.subjectAutologouses_ES
dc.titleRandomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0113936es_ES

Files in This Item:
Thumbnail
File
pone.0113936.pdf
Description
Size
655.82 kB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.